Tech Company Financing Transactions
Axonics Modulation Technologies Funding Round
On 6/30/2015, Axonics Modulation Technologies landed $17.3 million in funding from Edmond de Rothschild Investment Partners and NeoMed Management.
Transaction Overview
Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$17,282,000
Round
Undisclosed
Investors
Edmond de Rothschild Investment Partners (Raphaël Wisniewski)
NeoMed Management (Erik Amble)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
26 Technology Dr.
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Not Recorded
Overview
Axonics, based in Irvine, Calif., is a privately held venture-backed pre-revenue company developing novel implantable neuromodulation devices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raymond Cohen
Chief Medical Officer
Karen Noblett
Chief Operating Officer
Daniel Dearen
Chief Technical Officer
Guangqiang Jiang
VP - Bus. Development
Emilie Finiels
VP - General Counsel
Michael Williamson
VP - Marketing
John Woock
VP - Operations
Rinda Sama
VP - Product Management
Prabodh Mathur
Browse more venture capital transactions:
Prev: 6/30/2015: Tellit Health venture capital transaction
Next: 6/30/2015: Green Mountain Digital venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs